1-4 of 4
M Du
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Strategies for Delaying or Treating In vivo Acquired Resistance to Trastuzumab in Human Breast Cancer Xenografts

Free
Jeanne M. du Manoir, Giulio Francia, Shan Man, Miriam Mossoba, Jeffrey A. Medin, Alicia Viloria-Petit, Daniel J. Hicklin, Urban Emmenegger, Robert S. Kerbel
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (3): 904–916.
https://doi.org/10.1158/1078-0432.CCR-05-1109
Published: 07 February 2006
View articletitled, Strategies for Delaying or Treating In vivo Acquired Resistance to Trastuzumab in Human Breast Cancer Xenografts
Open the PDF for Strategies for Delaying or Treating In vivo Acquired Resistance to Trastuzumab in Human Breast Cancer Xenografts in another window
Journal Articles

Minimum dose of fludarabine for the maximal modulation of 1-beta-D-arabinofuranosylcytosine triphosphate in human leukemia blasts during therapy.

Free
V Gandhi, E Estey, M Du, M J Keating, W Plunkett
Journal: Clinical Cancer Research
Clin Cancer Res (1997) 3 (9): 1539–1545.
Published: 01 September 1997
View articletitled, Minimum dose of fludarabine for the maximal modulation of 1-beta-D-arabinofuranosylcytosine triphosphate in human leukemia blasts during therapy.
Open the PDF for Minimum dose of fludarabine for the maximal modulation of 1-beta-D-arabinofuranosylcytosine triphosphate in human leukemia blasts during therapy. in another window
Journal Articles

Irinotecan (CPT-11) metabolites in human bile and urine.

Free
F Lokiec, B M du Sorbier, G J Sanderink
Journal: Clinical Cancer Research
Clin Cancer Res (1996) 2 (12): 1943–1949.
Published: 01 December 1996
View articletitled, Irinotecan (CPT-11) metabolites in human bile and urine.
Open the PDF for Irinotecan (CPT-11) metabolites in human bile and urine. in another window
Journal Articles

Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemia.

Free
V Gandhi, E Estey, M Du, B Nowak, M J Keating, W Plunkett
Journal: Clinical Cancer Research
Clin Cancer Res (1995) 1 (2): 169–178.
Published: 01 February 1995
View articletitled, Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemia.
Open the PDF for Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemia. in another window